Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study
Zhengbo Song, Ziming Li, Yiping Zhang, et al.
Cancer Communications (London, England)
|
July 17, 2024
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)
Shun Lu, Xiaorong Dong, Hong Jian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2022
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations
Shun Lu, Xiaorong Dong, Hong Jian, et al.
Frontiers in Oncology
|
October 12, 2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
Long-Hua Guo, Ming-Feng Zhang, He-Long Zhang, et al.
JAMA Surgery
|
July 15, 2026
Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non-Small Cell Lung Cancer: Post Hoc Analysis of the Neotorch Randomized Clinical Trial
Wentao Fang, Yiyang Wang, Wenxiang Wang, et al.
JAMA
|
January 16, 2024
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial
Shun Lu, Wei Zhang, Lin Wu, et al.
Translational Lung Cancer Research
|
July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel
Yi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.
Thoracic Cancer
|
October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wenxian Wang, Qian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer
Shirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China
Xingxiang Pu, Chunwei Xu, Qian Wang, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2025
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study
Zhengbo Song, Ziming Li, Yiping Zhang, et al.
Cancer Communications (London, England)
|
July 17, 2024
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)
Shun Lu, Xiaorong Dong, Hong Jian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2022
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations
Shun Lu, Xiaorong Dong, Hong Jian, et al.
Frontiers in Oncology
|
October 12, 2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
Long-Hua Guo, Ming-Feng Zhang, He-Long Zhang, et al.
JAMA Surgery
|
July 15, 2026
Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non-Small Cell Lung Cancer: Post Hoc Analysis of the Neotorch Randomized Clinical Trial
Wentao Fang, Yiyang Wang, Wenxiang Wang, et al.
JAMA
|
January 16, 2024
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial
Shun Lu, Wei Zhang, Lin Wu, et al.
Translational Lung Cancer Research
|
July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel
Yi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.
Thoracic Cancer
|
October 21, 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wenxian Wang, Qian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer
Shirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Thoracic Cancer
|
September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China
Xingxiang Pu, Chunwei Xu, Qian Wang, et al.
Page
of 19